Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study

Ilenia Bartolini,Tommaso Nelli,Nadia Russolillo,Alessandro Cucchetti,Benedetta Pesi,Luca Moraldi,Alessandro Ferrero,Giorgio Ercolani,Gianluca Grazi,Giacomo Batignani
DOI: https://doi.org/10.1016/j.amjsurg.2021.01.023
Abstract:Background: Hepatocellular carcinoma (HCC) is frequently diagnosed as multinodular. This study aims to assess prognostic factors for survival and identify patients with multiple HCC who may benefit from surgery beyond the Barcelona Clinic Liver Cancer classification indications. Methods: This retrospective study included all the consecutive patients from 4 Italian tertiary centers receiving liver resection for naive multiple HCC between 1990 and 2012 to have a potential follow-up of 5 years. Results: Included patients were 144. Ninety-day morbidity and mortality rates were 38.3% and 8.3%, respectively. The 5-year overall and disease-free survival rates were 33.3% and 19.1%, respectively. Tumor size <3 cm, bilirubin, Child-Pugh A, BCLC-A stage, being within "up-to-7" criteria, and minor resections resulted in prognostic factors. The Child-Pugh score resulted in an independent prognostic factor. Conclusions: Surgery may be related to good outcomes in selected patients with multiple HCC.
What problem does this paper attempt to address?